Catalyst Wire Dossier Catalyst Wire Dossier

Umbilical Cord Mesenchymal Stem Cells (UC-MSC)

umbilical cord mesenchymal stem cells · Shenzhen Huishan Biotechnology Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Umbilical Cord Mesenchymal Stem Cells (UC-MSC), covering 2018-06-04 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Systemic Sclerosis [Phase 1, Phase 2]

See pricing